InterCure Investor

InterCure Ltd is an Israel-based medical device company. It is engaged in the production and sale of RESPeRATE, a Food and Drug Administration approved, non-drug, non-invasive hypertension treatment device. The Company’s patented device-guided breathing platform is used by RESPeRATE, and it enables a systematic reduction in sympathetic outflow of the autonomous nervous system.

Invests into

Technology: N/A
Industry: Personalized Medicine
Headquarters: Lod, HaMerkaz, Israel
Founded Date: 1996
Employees Number: N/A
Funding Status: N/A
Investor Type: N/A
Investment Stage: Undisclosed
Number Of Exits: N/A

Visit Website
Register and Claim Ownership